Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$2.77M Sell
16,758
-10,837
-39% -$1.67M 0.54% 45
2020
Q2
$3.78M Sell
27,595
-252
-0.9% -$32.9K 0.76% 33
2020
Q1
$3.28M Buy
27,847
+617
+2% +$81.2K 0.76% 34
2019
Q4
$3.6M Buy
27,230
+1,125
+4% +$140K 0.68% 36
2019
Q3
$3.25M Sell
26,105
-848
-3% -$102K 0.67% 36
2019
Q2
$3.06M Sell
26,953
-890
-3% -$93.2K 0.66% 38
2019
Q1
$2.8M Buy
27,843
+123
+0.4% +$11.2K 0.6% 39
2018
Q4
$2.37M Buy
27,720
+842
+3% +$75.8K 0.58% 39
2018
Q3
$2.46M Sell
26,878
-7,984
-23% -$708K 0.55% 44
2018
Q2
$2.97M Sell
34,862
-193
-0.6% -$16.3K 0.67% 38
2018
Q1
$2.93M Sell
35,055
-699
-2% -$55.1K 0.7% 36
2017
Q4
$2.58M Sell
35,754
-54
-0.2% -$3.71K 0.62% 39
2017
Q3
$2.28M Sell
35,808
-20,784
-37% -$1.3M 0.58% 43
2017
Q2
$3.53M Sell
56,592
-2
-0% -$118 0.99% 30
2017
Q1
$3.02M Sell
56,594
-43
-0.1% -$2.32K 0.83% 35
2016
Q4
$3.03M Sell
56,637
-1,185
-2% -$60.2K 0.85% 32
2016
Q3
$3.01M Sell
57,822
-458
-0.8% -$23.2K 0.84% 33
2016
Q2
$2.77M Buy
58,280
+2,259
+4% +$107K 0.8% 36
2016
Q1
$2.48M Buy
56,021
+4,805
+9% +$204K 0.77% 33
2015
Q4
$2.45M Buy
51,216
+2,715
+6% +$123K 0.71% 42
2015
Q3
$2M Sell
48,501
-1,674
-3% -$77.6K 0.68% 38
2015
Q2
$2.42M Sell
50,175
-1,578
-3% -$75.3K 0.75% 37
2015
Q1
$2.4M Sell
51,753
-124
-0.2% -$5.59K 0.8% 32
2014
Q4
$2.23M Sell
51,877
-14
-0% -$568 0.72% 36
2014
Q3
$1.92M Buy
51,891
+2,701
+5% +$92.5K 0.64% 41
2014
Q2
$1.59M Buy
49,190
+8,875
+22% +$272K 0.5% 45
2014
Q1
$1.17M Buy
40,315
+975
+2% +$29.8K 0.38% 55
2013
Q4
$1.29M Buy
+39,340
New +$1.25M 0.44% 48

Other funds holding ZTS

10-15 Associates's ZTS Position: Q3 2020 in Review

10-15 Associates reduced its Zoetis (ZTS) stake by 39% in Q3 2020, selling an estimated $1.67M and leaving 16,758 shares worth $2.77M. The position accounts for 0.54% of the portfolio, ranked #45.

10-15 Associates first reported a position in ZTS in Q4 2013 and has held it in 28 quarters since. The position peaked at $3.78M in Q2 2020. 1,308 funds tracked by Wall St. Rank hold ZTS as of Q3 2020.

  • 10-15 Associates held 16,758 shares of Zoetis worth $2.77M as of Q3 2020.
  • 10-15 Associates sold 10,837 Zoetis shares in Q3 2020, an estimated $1.67M.
  • Zoetis made up 0.54% of 10-15 Associates's portfolio in Q3 2020, its #45 holding.
  • 10-15 Associates first reported a position in Zoetis in Q4 2013 and has held it in 28 quarters since.
  • 10-15 Associates's Zoetis position peaked at $3.78M in Q2 2020.
  • 1,308 funds tracked by Wall St. Rank held Zoetis as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.